Cargando…
Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism
Background and aims: Vasoactive intestinal polypeptide type-I receptor (VIPR1) overexpression has been reported in numerous types of malignancies and utilized to develop novel target therapeutics and radiolabeled VIP analogue-based tumor imaging technology, but its role in liver carcinogenesis has n...
Autores principales: | Fu, Yaojie, Liu, Shanshan, Rodrigues, Robim M., Han, Ying, Guo, Cao, Zhu, Zhanwei, He, Yong, Mackowiak, Bryan, Feng, Dechun, Gao, Bin, Zeng, Shan, Shen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295067/ https://www.ncbi.nlm.nih.gov/pubmed/35864952 http://dx.doi.org/10.7150/ijbs.71134 |
Ejemplares similares
-
E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9
por: Rodrigues, Robim M., et al.
Publicado: (2021) -
MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types
por: Wang, Xiaolin, et al.
Publicado: (2021) -
Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm
por: Ge, Song, et al.
Publicado: (2022) -
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
por: Fu, Yaojie, et al.
Publicado: (2019) -
lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2022)